Novel role of NPY in neuroimmune interaction and lung growth after intrauterine growth restriction

Autor: Jörg Dötsch, Chansutha Thangaratnarajah, Jawed Nawabi, Julia Dobner, Kai D. Nüsken, Christian Klaudt, Stephan von Hörsten, Eva Lopez Garcia, Grazyna Kwapiszewska, Katharina Dinger, Christina Vohlen, Silke van Koningsbruggen-Rietschel, Miguel A. Alejandre Alcazar
Rok vydání: 2016
Předmět:
0301 basic medicine
Pulmonary and Respiratory Medicine
STAT3 Transcription Factor
medicine.medical_specialty
Sympathetic Nervous System
Physiology
Cell Survival
Rat model
Intrauterine growth restriction
Apoptosis
Biology
Weight Gain
Models
Biological

03 medical and health sciences
Cell Movement
Physiology (medical)
Internal medicine
medicine
Animals
Neuropeptide Y
Rats
Wistar

Myofibroblasts
Lung
Protein Kinase C
Cell Proliferation
Mice
Knockout

Neurotransmitter Agents
Fetal Growth Retardation
Interleukin-6
Adenylate Kinase
Cell Biology
Neuropeptide Y receptor
medicine.disease
humanities
Diet
Receptors
Neuropeptide Y

Mice
Inbred C57BL

Lung structure
030104 developmental biology
Endocrinology
medicine.anatomical_structure
Animals
Newborn

Gene Expression Regulation
Lung disease
Suppressor of Cytokine Signaling 3 Protein
Immunology
Biomarkers
Signal Transduction
Zdroj: American journal of physiology. Lung cellular and molecular physiology. 313(3)
ISSN: 1522-1504
Popis: Individuals with intrauterine growth restriction (IUGR) are at risk for chronic lung disease. Using a rat model, we showed in our previous studies that altered lung structure is related to IL-6/STAT3 signaling. As neuropeptide Y (NPY), a coneurotransmitter of the sympathetic nervous system, regulates proliferation and immune response, we hypothesized that dysregulated NPY after IUGR is linked to IL-6, impaired myofibroblast function, and alveolar growth. IUGR was induced in rats by isocaloric low-protein diet; lungs were analyzed on embryonic day (E) 21, postnatal day (P) 3, P12, and P23. Finally, primary neonatal lung myofibroblasts (pnF) and murine embryonic fibroblasts (MEF) were used to assess proliferation, apoptosis, migration, and IL-6 expression. At E21, NPY and IL-6 expression was decreased, and AKT/PKC and STAT3/AMPKα signaling was reduced. Early reduction of NPY/IL-6 was associated with increased chord length in lungs after IUGR at P3, indicating reduced alveolar formation. At P23, however, IUGR rats exhibited a catch-up of body weight and alveolar growth coupled with more proliferating myofibroblasts. These structural findings after IUGR were linked to activated NPY/PKC, IL-6/AMPKα signaling. Complementary, IUGR-pnF showed increased survival, impaired migration, and reduced IL-6 compared with control-pnF (Co-pnF). In contrast, NPY induced proliferation, migration, and increased IL-6 synthesis in fibroblasts. Additionally, NPY−/− mice showed reduced IL-6 signaling and less proliferation of lung fibroblasts. Our study presents a novel role of NPY during alveolarization: NPY regulates 1) IL-6 and lung STAT3/AMPKα signaling, and 2) proliferation and migration of myofibroblasts. These new insights in pulmonary neuroimmune interaction offer potential strategies to enable lung growth.
Databáze: OpenAIRE